![]() Karuna Therapeutics Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions. | |||
Founding Date | Founding Date 2000 | Founding Date 2009 | Founding Date 2021 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Helsingfors, FI HQ Frankfurt Am Main, DE Madison, US | Locations Boston, US HQ Boston, US Carmel, US | Locations San Francisco, US HQ |
Employees | Employees 40 | Employees 1919% increase | Employees 31 |
Valuation ($) | Valuation ($) 40 m | Valuation ($) 12.6 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €11m (FY, 2025) | Revenue (est.) $654k (FY, 2023) | Revenue (est.) N/A |
Net income | Net income €573k (FY, 2025) | Net income ($433.7m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 118.7m | Total funding raised $ 1.3m |

Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions.
View companyShareWell is a provider of online peer support for mental health therapy.
View company